含葡糖基酮洛芬乙烯醇酯共聚物的合成及其药物释放性能

分别利用化学法和酶促法合成了酮洛芬乙烯酯和葡萄糖丁二酸乙烯酯（6-O-乙烯丁二酰-D-葡萄糖）2种聚合单体,通过2种单体的自由基聚合反应制备了具有较高分子量的酮洛芬葡萄糖共聚物前药,通过IR、NMR对聚合物的结构进行了表征,用GPC方法测定共聚物分子量。 研究了聚合单体投料比例对共聚物分子量和载药量的影响。 结果表明,随着药物乙烯酯在投料中比例的增加,聚合物前药的分子量逐渐下降,聚合物中酮洛芬的载药量逐渐增加。 酮洛芬含糖聚合物前药的体外释放研究表明,酮洛芬的释放时间大大延长,达到了缓释的目的,释药速率随着聚合物前药中葡萄糖含量增加而加快。 聚合物前药的释放动力学模拟结果显示,共聚物释药更符合一级动力学释放模型。     

聚(L-谷氨酸)微球的制备及其口服药物控释研究

通过正己胺引发γ-苯甲基-L-谷氨酸酯-N-内羧酸酐(BLG-NCA)开环聚合制备聚(γ-苯甲基-L-谷氨酸酯)(PBLG), 并进一步脱掉苯甲基保护得到聚(L-谷氨酸)(PLG). 以利福平为模型药物, 通过油包油(O/O)无水乳液法制备了PLG载药微球. 扫描电子显微镜检测表明该载药微球具有良好的球形形貌且粒径分布较均一, 粒径大小约为9.0 μm. 体外释放实验表明该载药微球对利福平的释放具有明显的pH敏感性, 在模拟胃液中较少释放利福平, 而在模拟肠液中较快并大量释放利福平, 符合口服药物载体释放性能的要求, 可用于口服药物的定位肠溶性载体. 此外, 噻唑蓝实验表明该微球具有良好的生物相容性.     

低温辐射聚合制备聚合物药的慢释放研究

本文研究了低温辐射慢释放药的单体配比、药物含量及辐射刺量对药物释放速率的影响。结果表明,增加疏水性单体MMA,可以有效地控制大分子量药物消炎痛的释放速率;增加MMA及EDGMA,可以有效地控制小分子量药物5-Fu的释放速率;增加5-Fu的比例,可以降低5-Fu的释放速率;随辐照剂量的增加,聚合物药中5-Fu的释放量降低,二者之间成正比关系。     

萘普生在介孔分子筛MCM-41中的负载及其溶出性能

用含氨基的偶联剂修饰介孔分子筛MCM-41的表面,将修饰前和修饰后的介孔分子筛分别负载难溶性药物萘普生（NAP）,利用X射线衍射、傅里叶变换红外光谱、差示扫描量热分析、扫描电子显微镜、透射电子显微镜和N2吸附 脱附分析等技术分别对其进行了结构表征和性能测试。 结果表明,药物分子存在于分子筛的孔道中。 负载在MCM-41中的萘普生溶出速率远优于原料药,60 min时大约溶出70%。 氨基修饰后的药物释放速率比修饰前有所减慢,表明可通过氨基修饰调节释放速率。     

酮洛芬分子印迹拆分及分离过程热力学研究

利用非共价分子印迹法,采用4-乙烯基吡啶为功能单体,以二甲基丙烯酸乙二 醇酯为交联剂,在模板分子（S）-酮洛芬的存在下,制备出（S）-酮洛芬的分子印 迹聚合物（MIPs）,并用作HPLC固定相,对其进行了高效液相色谱评价。结果表明 外消旋酮洛芬在制备的印迹柱上得到了有效的分离,（S）-酮洛芬的容量因子 k_s'为9.52,选择性因子α为1.52,分离度R为0.88。此外,HPLC分析表明制备的 MIPs能够分离结构相似的酮洛芬、布洛芬和萘普生。研究了流动相中乙酸浓度、流 速及温度对拆分效果的影响,测定了分离过程中的焓变、熵变和自由能变化,对分 子印迹分离过程作了进一步解释。     

反丁烯二酸酯类共聚物的结构与性能

反丁烯二酸酯类单体的聚合反应研究结果表明,反丁烯二酸二异丙酯(DiPF)、反丁烯二酸二叔丁酯(DtBF)等单体形成的聚合物是一种具有较高分子量的非常脆的高分子材料;而由反丁烯二酸二正烷基酯,如反丁烯二酸二正丙酯(DnPF)等单体所形成的聚合物则是一种分子量较低的粘稠状聚合物。为了改善聚合物的力学性能,我们曾对DiPF和DtBF单体分别同反丁烯二酸二正丙酯(DnPF)、反丁烯二酸二正丁酯(DnBF)、反丁烯二酸二正戊酯     

脂肪酶催化一步酯化协同拆分合成S-萘普生淀粉酯前药

利用CRL脂肪酶选择性催化外消旋萘普生甲酯与玉米淀粉进行转酯化反应合成光学纯S-萘普生淀粉酯前药,同时达到拆分外消旋萘普生的目的。考察了有机溶剂、脂肪酶用量、底物浓度比、反应温度对酯化协同拆分反应的影响,结果表明在异辛烷中脂肪酶CRL可以催化S-萘普生甲酯与淀粉发生转酯化反应同时完成外消旋萘普生的拆分,并且在脂肪酶用量为10%、底物浓度比为1:3、异辛烷用量为15mL、反应温度为60℃的条件下反应6d,外消旋萘普生甲酯的转化率为27.2%,产物对应体过量值eep高达99.4%可以作为萘普生的前药进行应用。     

乙二醇-聚(咪唑丙基-天冬酰胺)-聚丙氨酸三嵌段共聚物的合成及其pH-响应性药物控制释放性能的研究

聚天冬氨酸及其衍生物是一种具有良好生物相容性和可生物降解性的高分子材料, 被广泛应用于生物医药领域. 本研究通过大分子引发剂ω-胺基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和N-(3-氨丙基)咪唑侧基改性, 制备了一种侧链含有咪唑丙基的聚乙二醇-聚(咪唑丙基-天冬酰胺)-聚丙氨酸三嵌段共聚物. 在水溶液中, 此聚合物可自组装形成一种核-壳-冠型的三层共聚物胶束, 其中疏水性的聚丙氨酸链段自聚集形成胶束的核, 聚(咪唑丙基-天冬酰胺)链段形成具有pH-响应性的壳层, 用于包埋和释放药物, 外围的聚乙二醇链段可以提供一个稳定的水合冠层, 延长药物的体内循环时间. 利用咪唑环与游离阿霉素之间的π-π相互作用和疏水相互作用可以在自组装的过程中将阿霉素包埋到胶束内. 研究发现, 载药胶束随环境pH 值的降低药物的释放速率显著增加. 这主要是由于咪唑环在酸性条件下的质子化导致链段亲疏水性质发生明显变化.     

几种手性原子转移自由基聚合引发剂的合成及其在螺旋选择性聚合中的应用

合成了(S)-2,2'-二(溴甲基)-1,1'-联萘, (S)-2'-甲基-2-溴甲基-1,1'-联萘, α-溴代苯乙酸薄荷酯, N-薄荷基-α-溴代苯乙酰胺和α-溴代苯乙酸胆甾烷醇酯5种旋光的溴代烷并将其用作非手性单体甲基丙烯酸-1-苯基二苯并环庚醇酯 (PDBSMA)的原子转移自由基聚合(ATRP)的手性引发剂. 为了使这些手性引发剂在引发一步生成的初级自由基不发生消旋化, 引发剂中的手性中心都不直接与溴原子相连. 用这5种手性溴代烷做引发剂引发PDBSMA的ATRP所得聚合物可分成四氢呋喃(THF)可溶部分和THF不溶部分. THF可溶部分具有较大的比旋光度. 对THF可溶部分的手性光学性质研究以及比较该部分聚合物和在同样引发条件下得到的甲基丙烯酸甲酯聚合物的比旋光度, 我们得出聚合物大的比旋光度是由聚合物单手性螺旋过量引起的结论, 即合成的手性引发剂对PDBSMA的ATRP均有一定的螺旋选择性, 其中(S)-2,2'-二(溴甲基)-1,1'-联萘、(S)-2'-甲基-2-溴甲基-1,1'-联萘螺旋选择性最好. 引发剂的螺旋诱导能力跟聚合反应的温度有很大关系, 聚合温度上限为70 ℃, 在0～70 ℃之间, 随着温度的升高引发剂的螺旋选择性逐渐增强.     

反丁烯二酸酯的自由基共聚反应

<正> 对反丁烯二酸酯(DRPs)类单休的均实反应研究已有许多报道。研究结果表明,所有的正烷基酯基DRFs单体,如反丁烯二酸二王丙酯等,均表现出很低的聚合反应活性,因而得不到高分子量的均聚物;而某些非正烷基酯的DRFs单体,如反丁烯二酸二异丙酯则显示出很高的聚合反应活性并可形成高分子量的聚合物。对反丁烯二酸酯同其他乙烯类单体(如苯乙烯等)的共聚研究曾有一些报道,但对DRFs单体之间的共聚     

二氧化碳和丙烯直接合成甲基丙烯酸的NiPMo/TiO2催化剂的研究

用溶胶-凝胶法以磷钼酸(MPA)的镍盐溶液水解钛酸四丁酯制备了NiPMo/TiO2催化剂.使用ICP、 XRD、 TG-DTA、 IR、 TPD-MS和微反应技术研究了催化剂的化学组成、热稳定性、化学吸附性质和催化反应性能.杂多钼酸盐与TiO2通过O2-在TiO2表面发生了键合.在623 K下,杂多阴离子仍保持原有的Keggin结构.CO2在Lewis酸位Ni(Ⅱ)和Lewis碱位Ni-O-Mo的桥氧协同作用下生成CO2卧式吸附态Ni(Ⅱ)←O-(CO)←(O--Ni).丙烯有多种吸附态在催化剂上吸附.在563 K、 1 MPa和空速1500 h-1的反应条件下,丙烯的摩尔转化率为3.2%,产物MAA选择性为95%.     

Synthesis of 1-benzyloxypyrazin-2(1H)-one derivatives

Different approaches for the synthesis of 1-benzyloxypyrazin-2(1H)-one derivatives from simple amino acids have been investigated. A library of 33 precursors for the preparation of N-hydroxy pyrazinones was obtained in moderate to good yields.     

α-Amino acid derived enaminones and their application in the synthesis of N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates and other heterocycles

A new and simple synthesis of novel N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates, which exist in equilibrium with their 4-oxo tautomers, has been developed in two steps starting from N-protected α-amino acids. The key intermediates are enaminones, which can also be isolated, characterized, and used for the construction of other functionalized heterocycles, before they spontaneously decompose to pyrrole products. 4-Hydroxypyrroles are prone to partial aerial oxidation but can be efficiently alkylated or reduced to stable polysubstituted pyrrolidine derivatives.     

Specific intramolecular aromatic CH insertion of diazosulfonamides

The chemoselectivity in the intramolecular CH insertion of various diazosulfonamides has been experimentally studied. The results reveal that the aliphatic 1,4-, 1,5-, or 1,6-C(sp³)?H insertions of diazosulfonamides are not accessible, while the aromatic 1,5-C(sp²)?H insertion can be realized specifically by adjusting the diazo-adjacent group. In addition, the general chemoselectivities in the intramolecular CH insertions of diazosulfonyl compounds are summarized. Generally, diazosulfones undergo both aromatic 1,5-C(sp²)?H and aliphatic 1,5- and 1,6-C(sp³)?H insertions, while diazosulfonates undergo aliphatic 1,5- and 1,6-C(sp³)?H insertions. However, diazosulfonamides only undergo aromatic 1,5-C(sp²)?H insertion.     

A general and convenient synthesis of 4-(tosylmethyl)semicarbazones and their use in amidoalkylation of hydrogen,heteroatom, and carbon nucleophiles

A general synthesis of previously unknown semicarbazone-based α-amidoalkylating reagents, 4-(tosylmethyl)semicarbazones, has been developed. The synthesis involved three-component condensation of semicarbazones of aliphatic or aromatic aldehydes with the same or other aldehydes and p-toluenesulfinic acid. The scope and limitations of this reaction were investigated. The compounds obtained were demonstrated to be an efficient α-(4-semicarbazono)alkylating agents. They were reacted with H- (sodium borohydride), O- (sodium methylate), S- (sodium phenylthiolate), N- (pyrrolidine, sodium succinimide), P- (trialkyl phosphites), and C-nucleophiles (sodium diethyl malonate) to give the corresponding products of the tosyl group substitution, 4-substituted semicarbazones, including analogues of nitrofurazone. Among the prepared compounds tested in vitro for antibacterial and antifungal activity, three nitrofuryl-containing semicarbazones exhibited high biological activities with minimum inhibitory concentration (MIC) values of 8–32 μg/mL.     

Toward new camptothecins. Part 6: Synthesis of crucial ketones and their use in Friedländer reaction

In the context of the preparation of camptothecin and luotonin A analogs, the synthesis of some key keto-precursors and their use in Friedländer condensation are described. This paper also focuses on the stability of these keto intermediates and emphasizes the major differences between indolizinones and pyrroloquinazolinones series. Noteworthy is also the report of some original structures isolated as by-products of some experiments.     

Synthesis of novel chiral bidentate hydroxyalkyl-N-heterocyclic carbene ligands and their application in palladium-catalyzed Mizoroki–Heck couplings and asymmetric addition of diethylzinc to benzaldehyde

A small library of new chiral bidentate hydroxyalkyl-imidazolium salts 1 is conveniently synthesized on multi-gram scale from inexpensive and commercially available chiral pool amino acids. The corresponding carbenes, generated by deprotonation of imidazolium salts 1, in combination with palladium(II) chloride were tested in the Mizoroki–Heck coupling reaction. The most significant results in terms of yields and reactivities were achieved with low catalyst loading. The catalytic activities of these imidazolium salts were also investigated in the asymmetric addition of diethylzinc to benzaldehyde. The use of MgO nanoparticles as an additive in conjunction with these ligands played a crucial role in increasing the efficiency of these reactions.     

N-Heterocyclic carbene-palladacyclic complexes: synthesis,characterization and their applications in the C-N coupling and α-arylation of ketones using aryl chlorides

N-Heterocyclic carbene-palladacyclic complexes 3 were successfully achieved in a one-pot procedure under mild conditions. The structure of 3a was unambiguously confirmed by X-ray single crystal diffraction and it was an active catalyst in the Buchwald-Hartwig amination and α-arylation of ketones even at very low catalyst loadings (0.01?mol%).     

Iodine-mediated oxidative Pictet-Spengler reaction using terminal alkyne as the 2-oxoaldehyde surrogate for the synthesis of 1-aroyl-β-carbolines and fused-nitrogen heterocycles

An efficient iodine-mediated oxidative Pictet-Spengler reaction in dimethyl sulphoxide (DMSO) using terminal alkynes as the 2-oxoaldehyde surrogate for the synthesis of aryl (9H-pyrido[3,4-b]indol-1-yl)methanones is described. The scope of the protocol includes the total synthesis of Fascaplysin, Eudistomins Y₁ and Y₂. The methodology is extended for preparing pyrrolo[1,2-a]-quinoxaline and indolo[1,5-a]quinoxaline derivatives. The utility of 1-aroyl-β-carbolines was demonstrated by performing palladium-catalyzed β-carboline directed ortho-C(sp2)-H functionalization of the phenyl ring with thiomethyl (SMe) group using DMSO as source and for accessing 4-aryl-canthin-6-ones.     

Facile synthesis of bicyclic 1-arylpyrazol-5-ones

In this Letter, we described a facile method for constructing fused bicyclic 1-arylpyrazol-5-one ring system. We employed various methylene-containing carboxylic acids as the substrates and proved that the pyrazolone ring closure requires activated methylene group in intermediate II. Accordingly, a series of structurally diversified, fused bicyclic 1-arylpyrazol-5-ones was prepared in moderate to high yields using the requisite substrates.